can glp-1 and dpp4 be used together do not combine dpp-4 inhibitors with receptor agonists guidance Comparison of DPP-4 and GLP-1 Combination: Safety – GLP 1 Receptor Agonists and

Accordingly, it may be reasonable to preferentially initiate patients with T2D and a history of stroke on a GLP-1RA as the first agent prior to using an SGLT2 inhibitor

GHRH analog without drug affinity complex

The rare serious side effects require awareness and physician monitoring

Common short-term side effects may include: Temporary water retention or bloating Mild joint stiffness or tingling Flushed skin or warmth at injection site Slight headache or fatigue (especially when beginning use) Peptide secretagogues like Ipamorelin appear to exhibit fewer adverse effects than GH or GHRH analogs and are highly selective for the GH axis (Smith et al., Journal of Endocrinological Investigation )

Propylthiouracil inducible glutathione transferases